2014 Canadian Melanoma Conference
 

2014 Conference

The 2014 Canadian Melanoma Conference will take place at the Rimrock Resort Hotel February 20 to 23, 2014

Overview

Download the PDF Program.

Presentations from this year's Conference are now available and are listed below in order of program appearance:

Dr. Hensin Tsao, Update on the Hereditary Melanoma
Dr. Martin Trotter, Pathology Error in the Diagnosis and Staging of Cutaneous Melanoma
Dr. Arjun Sahgal, SRS for Brain Metastases - No More Whole Brain Radiation
Dr. Christopher Bichakjian, Update on the Use of Sentinel Lymph Node Biopsy for Melanoma
Dr. Ashfaq Marghoob, Melanocytic Lesion Volatility in Patients on BRAF Inhibitors
Dr. Paul Kuzel, A Clinicoepidemiological Study of Pediatric Melanoma in Alberta, Canada from 1992-2011
Dr. Vernon Sondak, Management of Pediatric Melanoma and Atypical Melanocytic Neoplasms: A Growing Problem
Dr. Mark Faries, Sentinel Node: Controversies and MSLT Update
Dr. Charles Balch, The Future of Melanoma Management
Dr. Jeffery Weber and Dr. Mateya E. Trinkaus, Demystifying Myths in Metastatic Melanoma
Dr. Scott Ernst, Case Study Presentation
Dr. Jeffery Weber, Clinical and Biomarker Studies of Nivolumab, a PD-1 Blocking Antibody in Melanoma
Dr. Ryan Sullivan, Grand Unification: The Rationale for Combining Immunotherapy with Molecularly Targeter Therapy
Dr. David Hogg, Trouble with Trials

The Canadian Melanoma Conference is Canada's flagship meeting on the research and treatment of melanoma. It brings together Medical Oncologists, Surgeons, Dermatologists, Radiotherapists, Pathologists, Molecular Biologists, and Immunologists to review the latest evidence and explore new therapies.

  • Identify new targets and targeted agents in the treatment of melanoma such as PD-1
  • Identify key industry partners who would prioritize the development of products and programs in melanoma management in Canada
  • Continue to build the network of basic and clinical investigators in order to promote translational and clinical research across Canada
  • Discuss short- and long-term research strategies

Accreditation

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and is approved by the University of Calgary Office of Continuing Medical Education and Professional Development. Participants can claim up to a maximum of 12 study credits. 

Program Planning Committee

Chair: Michael Smylie, Medical Oncologist, Department of Medical Oncology, Cross Cancer Institute; Professor, University of Alberta

Joel Claveau, Melanoma and Pigmented Lesions Clinic, Hôpital Hôtel-Dieu de Québec

Scott Ernst, Head, Division of Medical Oncology, London Regional Cancer Program

David Hogg, Professor of Medicine, Departments of Medicine and Medical Biophysics, University of Toronto

Greg McKinnon, Professor of Surgery and Oncology, University of Calgary and Tom Baker Cancer Centre

Teresa Petrella, Medical Oncologist, Sunnybrook Odette Cancer Centre

Thomas Salopek, Director of Dermatology, Associate Professor, University of Alberta

Alan Spatz, Professor of Pathology and Oncology, Department of Pathology, McGill University